250 likes | 474 Views
Personalized medicine and oncosurgery. O .Topolčan, V. Třeška. Teaching Hospital Plzeň, Faculty of Medicine in Plzeň, Charles University in Prague Czech Republic. Presentation structure. Personalized medicine and cancer Clinical use of biomarke r s assessment Our results
E N D
Personalized medicine and oncosurgery O.Topolčan, V. Třeška Teaching Hospital Plzeň, Faculty of Medicine in Plzeň, Charles University in PragueCzech Republic
Presentation structure • Personalizedmedicineandcancer • Clinical use of biomarkers assessment • Our results • Conclusions for clinical practice • Final goal
Todays x personalized • Todaysdiagnostics • Fromsymptoms to diagnosis • Empiricorcausaltherapy Personalizedmedicine • Moleculardiagnostic – biomarkers, genomic, • - omixmethod • Therapystratifed - individualised
Impact of MolecularDiagnostics on theManegement of Cancer • Clasficacation of cancer • Risk assesmentandprognosis • Prediction of response to treatment • Guide to therapeutics
Clasification of cancer • Analysis of RNA splicingevent in cancer • Cancerclassificationusingmicroarrays • Cancerstratificationbased on methlation markers • Analysis of chromosomalalteration of cancercells • Detection of loss of hererozigosity (LOH) • Diagnosis of cancer of anunkownprimary • Diagnosticsfordetection of minimalresidualdisease
Risk asesmentandprognosis • Cancerprognosis • Detection of mutationsfor risk asessmetandprevention
Prediction of responce to treatment • Biopsytesting of tumorsforchemotherapy sensitivity • Genomicanalysis of tumor biopsies to predict response to treatment • Serumnucleosides as indicators of sensitivity as chemotherapy • Testingmicrosatelliteinstabililityforrespose to chemotherapy • Prediction of response to radiationtherapy
Guide to therapeutics • Diagnosticsfordetection of Multidrugresistency • Detection of resistence to chemotherapy • Moleculardiagnosticscombinedwithcancertherapeutics • Drugdiscoveryanddevelopment • Design of futurecancertherapies • Screeningforpersonalizedanticancerdrug • Pharmacogenomic test forstratification of clinicaltrials
Current status • Routine • Biomarkers = tumor markers • High PPV, Low NPV, Low sensitivity andspecicifity • Indication • Follow-up of cancer disease
Ourreults Metastatic proces in Liver
New ourapproachforClinical use of biomarkers • Targetquestionandtargetbiomarkers • Multidiscplinedapproach • Multiparametrdiagnostics • Multiplex andOptimal therapy choice of surgery procedure
Metastasisresection • Preoperativandpooperativfor prognosis: • Tumor markers CEA, CA 19-9, cytokeratins, • AngiogenoticfactorOPR, OPN, PRL, VEGF, • GrowthfactorHGF, IGF -1, IGFBP 3, 7 • MMP 7, 9 TIMP-1 • Gene expression K-ras, p53, HER-2 neu, TIMP-1, MMP 7, 9 Predictionforprogresion • CEA, circulating cancer cells or circulating DNA • D vitamine
RFA • Preoperativandpooperativfor prognosis: • Tumor markers CEA, CA 19-9, cytokeratins, • AngiogenoticfactorOPR, OPN, PRL, VEGF, • GrowthfactorHGF, IGF -1, IGFBP 3, 7 • MMP 7, 9 TIMP-1 • Gene expression K-ras, p53, HER-2 neu, TIMP-1, MMP 7, 9 Predictionforprogresion • CEA, circulating cancer cells or circulating DNA • D vitamine cytokeratine
Portalveinembolism • Aimfor vyšetření – predictterapeuticeffect • goodresponce – regeneration • poorresponce - minimalgrowth • Tumor progresion
Portalveinembolism • Imaing technik – expensiv, slowchangis • Markes – research – in ourlaboratory • Cytokeratins • Cytokains – inflamatory IL • Angiogenetics – OPG, OPN • Growth IGF-1
IGF -1 • Anti-apoptotic activity • Mitotic activity • MMP-7 activation • IGFBP3 inhibition • Correlation between IGF1 and Multidrug Resistance-Associated Protein-1 (MDR -1) • Inverse correlation with adiponectin
Adiponectin • Breast cancer • MMP-7 inhibition, favorable prognosis • Anti-angiogenetic effect • Gastric cancer • Angiogenesis inhibition, • apoptosis activation, favorable prognosis • Prostate cancer • Controversial results
Prolactin • Angiogenesis stimulation • Adhesion molecules stimulation • Metastatic potentiating of tumor • CRC - unfavorable prognosis
Why do we need this knowledge • Prevention • Diagnostics • Prognosis estimation • Follow-up • Therapy • Optimal therapy choice • New therapy choice – personalized medicine
Prevention Targeted prevention • Active screening of patients for the risk of cancer occurence • Stratificationpopulation • Targeted prevention method • Targeted prevention monitoring
Diagnosis ! Not (so far) ? Hopefully in future ??
Prognosis a prediction • Prognosis preoprativfor DFI and OS • Prediction of surgeryeffectfordiferent type operationion • Residual • Postoperativchekingandprognosisfor DFI and OS • Follow-upandpredictionrelaps • Early detection of disease progression
Final goal • Improvement to the quality of life of cancer patients • DFI and OS extension
Thank you for your attention